Literature DB >> 19425128

Optimality criteria for the prediction of metabolic fluxes in yeast mutants.

Evan S Snitkin1, Daniel Segrè.   

Abstract

Constraint-based models of cellular metabolism, such as flux balance analysis (FBA), use convex analysis and optimization to study metabolic networks at a genome scale. The availability of reaction lists for numerous organisms, along with a variety of network analysis and optimization tools, is making these approaches increasingly popular for metabolic engineering and biomedical applications, as well as for addressing fundamental biological questions. It is therefore very important to assess the predictive capacity of these models and to understand how to interpret them in a biologically relevant manner. Typically, model assessment is limited to gauging the ability to predict phenotypes, such as viability under different environmental and genetic conditions. These types of assessments, for the most part, focus only on the growth phenotype of the cells, but ignore the underlying flux predictions. While this may be sufficient for certain types of study, the question of whether flux balance models can reliably predict intracellular and transport fluxes is crucial for more detailed analysis, and remains largely unanswered. Here we compare FBA model predictions of yeast metabolic fluxes to a previously published set of experimentally determined fluxes for 13 different single gene deletion mutants across a variety of possible objective functions. We find that the specific optimization criteria used to determine fluxes have a significant impact on the accuracy of the predicted fluxes. Interestingly, while different optimization methods provide very different levels of agreement relative to experimental fluxes, they tend to provide similar predictions with respect to the effect of the perturbation on growth. This demonstrates that assessment of models at the level of flux predictions is a critical step in assessing the biological validity of different models and optimization criteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19425128

Source DB:  PubMed          Journal:  Genome Inform        ISSN: 0919-9454


  8 in total

Review 1.  Optimality models in the age of experimental evolution and genomics.

Authors:  J J Bull; I-N Wang
Journal:  J Evol Biol       Date:  2010-07-14       Impact factor: 2.411

2.  Environments that induce synthetic microbial ecosystems.

Authors:  Niels Klitgord; Daniel Segrè
Journal:  PLoS Comput Biol       Date:  2010-11-18       Impact factor: 4.475

3.  Model-based confirmation of alternative substrates of mitochondrial electron transport chain.

Authors:  Sabrina Kleessen; Wagner L Araújo; Alisdair R Fernie; Zoran Nikoloski
Journal:  J Biol Chem       Date:  2012-02-09       Impact factor: 5.157

4.  Genomic analysis of Saccharomyces cerevisiae isolates that grow optimally with glucose as the sole carbon source.

Authors:  Anthony D Aragon; Norah Torrez-Martinez; Jeremy S Edwards
Journal:  Electrophoresis       Date:  2012-11-08       Impact factor: 3.535

5.  A computational exploration of bacterial metabolic diversity identifying metabolic interactions and growth-efficient strain communities.

Authors:  Eleftheria Tzamali; Panayiota Poirazi; Ioannis G Tollis; Martin Reczko
Journal:  BMC Syst Biol       Date:  2011-10-18

6.  Predicting growth conditions from internal metabolic fluxes in an in-silico model of E. coli.

Authors:  Viswanadham Sridhara; Austin G Meyer; Piyush Rai; Jeffrey E Barrick; Pradeep Ravikumar; Daniel Segrè; Claus O Wilke
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

7.  Influence of Glucose Availability and CRP Acetylation on the Genome-Wide Transcriptional Response of Escherichia coli: Assessment by an Optimized Factorial Microarray Analysis.

Authors:  Daniel V Guebel; Néstor V Torres
Journal:  Front Microbiol       Date:  2018-05-23       Impact factor: 5.640

8.  A framework for evolutionary systems biology.

Authors:  Laurence Loewe
Journal:  BMC Syst Biol       Date:  2009-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.